Core Biogenesis Releases New Clinical Data on Peaureva™ Scalp Active at in-cosmetics Global 2026

Core Biogenesis has released new biotech data on Peaureva™, its novel scalp active based on an oleosome-growth factor fusion technology, ahead of its presentation at in-cosmetics Global 2026 in Paris. Early clinical results demonstrate a +33.6% increase in hair density in just 28 days, positioning Peaureva™ as one of the most compelling new scalp biotechnology actives to emerge in the hair thinning segment. The active targets five biological drivers of hair thinning, making it relevant across a broad spectrum of hair loss concerns for formulators developing next-generation scalp treatments…